Seminar 1 - 2018 Academy Seminars Individual learning assessment questionnaire

Please find below the correct answers to the 2018 Academy Seminars individual learning assessment questionnaire:

1. Is it always possible to solve the problem of drug shortages by just switching the supplier?

2. Will other suppliers of the same drug will be able to meet demand of market in case of drug shortages from other suppliers?

3. Is it necessary to involve other health-care professionals if drug shortages occur?

4. COST is the abbreviation for "cooperation in science and technology" and represents a platform enabling scientific and technological break-through, however without direct funding.

5. The main achievement of the COST Action CA 15105 on mediciens shortages was the agreement between manufacturers and hospital pharmacists on a common definition of the term "shortage" being an out-of-stock situation of life-saving medicines for more than three weeks.

6. One of the major shortcoming in the fight against shortages is the lack of sensibility and will to share responsibilities.

7. Should a patient-clinicalneedsassessment be considered whenchoosing a substutituteduring a medicine's shortage?

8. On what grounds is a critical medicine based when there is a medicine shortage?
• Therapeutic use
• The number of alternatives available
• The history of previous shortages
• All the above

9. What comes under assessment when the clinical risk of a shortage is assessed:
• The consequence(s) of a treatment delay
• Additional monitoring if an alternative is introduced
• Additional drug-drug interactions if an alternative is introduced
• Possible treatment onset after the alternative is introduced
• All the above

10. In a situation of a limited availability of health care services (including scarce supplies and a limited availability of medicines), does the inevitable rationing include all or only part of the following criteria (rules): ethical rules, rules of choice among individuals, rules of effect, procedural rules?
• Yes, all of them
• No, only part of them

11. On the level of the European Union, drug shortages have the following significant implications:
• only clinical implications
• clinical but also economic implications
• clinical, economic, as well as policy implications

12. Please, indicate to which opinion you are currently inclined:
• Predominantly, drug shortages are a problem of medical or pharmaceutical nature
• Drug shortages stem from societal choices on organizing markets, regulatory systems and health care services

13. Causal simulation models have been developed for only describing past behavior.

14. In simulation modelling, a stock is an accumulation of entities over time. A stock can only be changed by its respective flows.

15. The purpose of system dynamics simulation modelling is to understand and manage dynamic complexity.

16. Do drug shortages implement a financial risk for hospitals?

17. Can hospital pharmacy drug production solve drug shortages?

18. Do drug shortages create a high workload by looking for other supply chains?

19. An agreement between the Swiss Association of Hospital Pharmacists and the local pharma industry on provision of APIs in case of supply chain disruptions has contributed to a stabilisation of the number of medicines shortages.

20. An agreement between the Swiss Federal Office for National Economic and the local pharma industry on compulsory stocks of life-saving medicines has contributed to bridging gaps in case of medicines shortages.

21. Hospital Pharmacy manufacturing is an important shortages-coping strategy from a point of view of public health and regulation authorities.

22. Does prospective risk assessment in medicine shortages facilitate risk prioritisation before control measures are put into place?

23. Healthcare failure mode and effect analysis (HFMEA) consists of what?
• Forming a multidsciplinary team
• Defining the topic of analysis
• Graphically describing the process
• Conducting a hazard analysis
• Proposingactions to be taken
• All the above

24. What is possible through the implementation of HFMEA?
• Detect weaknesses in a selected process
• Determinecauses
• Decribe the possible effects of each cause
• All the above

Last update: 20 October 2018